Search
5 results for “Brazilian pharmacy”
Mounjaro Launch Fuels Surge in Brazilian Pharmacy Sales as GLP-1 Battle Intensifies
Eli Lilly's tirzepatide, Mounjaro, has become a high-margin sales driver for major Brazilian pharmacy chains like Raia Drogasil.
ANVISA Opens Brazilian E-commerce to Pharmacy Drug Sales, Modernizing Supply Chain
Brazil's health regulator, ANVISA, revoked a restriction on medicine sales, allowing licensed pharmacies to use major e-commerce platforms like Mercado Livre and Shopee for logistics and delivery, opening a massive new vertical for the digital retail sector.
Pague Menos Posts Record 6.5% EBITDA Margin for Q2 2026, But Financial Costs and SSS Slowdown Temper Net Income Growth
Brazilian pharmacy chain Pague Menos (PGMN3) hit a record operational margin in 2Q26, though rising financial expenses and slower same-store sales growth limited net income.
Pague Menos Posts Record 6.5% EBITDA Margin Despite Sales Miss, Driven by Efficiency Gains
Brazilian pharmacy chain Pague Menos (PGMN3) achieved a record 6.5% adj. EBITDA margin in Q2 2026, defying a 9.3% sales miss.
Mercado Livre Ozempic Deal Sparks Overdone Drugstore Selloff
Brazilian pharmacy stocks RD Saúde and Pague Menos fell on Mercado Livre's Mexican GLP-1 deal, but analysts say strict domestic regulations protect local players.